AWM
AGN

Aevitas Wealth Management’s Allergan plc AGN Stock Holding History

Aevitas Wealth Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-706
Closed -$103K – 386
2019
Q1 		$103K Sell
706
-1,410
-67% -$204K 0.09% 137
2018
Q4 		$283K Buy
2,116
+2
+0.1% +$328 0.29% 80
2018
Q3 		$403K Buy
2,114
+2
+0.1% +$367 0.36% 71
2018
Q2 		$352K Sell
2,112
-57
-3% -$9.15K 0.34% 73
2018
Q1 		$365K Sell
2,169
-323
-13% -$54.2K 0.36% 69
2017
Q4 		$408K Buy
+2,492
New +$447K 0.39% 66

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aevitas Wealth Management's AGN Position: Q2 2019 in Review

Aevitas Wealth Management sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 706 shares — an estimated $103K sold.

Aevitas Wealth Management first reported a position in AGN in Q4 2017 and held it in 6 quarters. The position peaked at $408K in Q4 2017. 970 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • Aevitas Wealth Management reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • Aevitas Wealth Management sold 706 Allergan plc shares in Q2 2019, an estimated $103K.
  • Aevitas Wealth Management first reported a position in Allergan plc in Q4 2017 and held it in 6 quarters.
  • Aevitas Wealth Management's Allergan plc position peaked at $408K in Q4 2017.
  • 970 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on Aevitas Wealth Management's 13F filing for Q2 2019, filed 26 Jul 2019.